Curaleaf Holdings (CURLF) Invested Capital (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Invested Capital of $156.1 million for Q4 2025, down 3.43% year-on-year from $161.7 million in Q4 2024, and down 3.43% on a QoQ basis from $161.7 million in Q4 2024.
Curaleaf Holdings (CURLF) Invested Capital (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Invested Capital for 7 consecutive years, with $156.1 million the latest figure, recorded in Q4 2025.
- Quarterly Invested Capital fell 3.43% year-over-year to $156.1 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $156.1 million (down 11.82% YoY) and the FY2025 annual result came in at $156.1 million, down 3.43% from the prior year.
- Invested Capital declined to $156.1 million in Q4 2025 per CURLF's latest filing, from $161.7 million in the prior quarter.
- Over the last five years, Invested Capital for CURLF reached as high as $28.8 billion in Q1 2022 and fell as low as $4.2 million in Q1 2021.
- A 5-year average of $2.0 billion and a median of $23.5 million in 2022 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital soared 686926.0% — and 2024, when it slumped 90.82%.
- Year by year, Invested Capital stood at $9.2 million in 2021, then soared by 1819.73% to $175.8 million in 2022, then fell by 3.62% to $169.4 million in 2023, then dropped by 4.55% to $161.7 million in 2024, then decreased by 3.43% to $156.1 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $156.1 million, $161.7 million, and $5.7 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 156.13 Mn |
| Dec 31, 2024 | 161.68 Mn |
| Sep 30, 2024 | 5.71 Mn |
| Jun 30, 2024 | 9.67 Mn |
| Dec 31, 2023 | 169.39 Mn |
| Sep 30, 2023 | 62.25 Mn |
| Jun 30, 2023 | 48.47 Mn |
| Dec 31, 2022 | 175.75 Mn |
| Sep 30, 2022 | 23.48 Mn |
| Jun 30, 2022 | 20.96 Mn |
| Mar 31, 2022 | 28.81 Bn |
| Dec 31, 2021 | 9.16 Mn |
| Sep 30, 2021 | 9.16 Mn |
| Jun 30, 2021 | 9.16 Mn |
| Mar 31, 2021 | 4.19 Mn |
| Dec 31, 2020 | 6.50 Mn |
| Sep 30, 2020 | 9.70 Mn |
| Dec 31, 2019 | 17.00 Mn |